Feasibility of Huntington disease trials in the disease prodrome

Neurology. 2014 Mar 11;82(10):824-5. doi: 10.1212/WNL.0000000000000197. Epub 2014 Feb 7.

Authors

Elizabeth A McCusker¹, Richard H Myers

Affiliation

¹ From the Department of Neurology (E.A.M.), Westmead Hospital, and Sydney Medical School, University of Sydney, Australia; and Department of Neurology (R.H.M), Genome Science Institute, Boston University School of Medicine, Boston, MA.

PMID: 24510495
DOI: 10.1212/WNL.0000000000000197

No abstract available

Publication types

Editorial
Comment

MeSH terms

Brain / drug effects*
Cognition Disorders / prevention & control*
Creatine / pharmacology*
Humans
Huntington Disease / prevention & control*

Substances

Creatine

Grants and funding

R01 NS073947/NS/NINDS NIH HHS/United States